Brief: Citadel Advisors Reports 6.9% Passive Stake In Benitec Biopharma Inc. As Of Aug 11, 2023- SEC Filing
Aug 21 (Reuters) - Benitec Biopharma Inc BNTC.O :
* CITADEL ADVISORS LLC REPORTS 6.9% PASSIVE STAKE IN BENITEC
BIOPHARMA INC. AS OF AUGUST 11, 2023- SEC FILING
Source text for Eikon: ID:
Further company coverage: BNTC.O
(Reporting by Zaheer Kachwala)
((Zaheer.Kachwala@thomsonreuters.com;))